MONTREAL, May 1 /PRNewswire-FirstCall/ - ProMetic Life Sciences Inc.
("ProMetic") (TSX:PLI) will host its Annual and Special Meeting of
Shareholders on Wednesday, May 7, 2008 at 10:30 a.m. (EDT). The Annual and
Special Meeting of Shareholders ("Meeting") will be held at the Montreal
Museum of Fine Arts located at 1379 Sherbrooke Street West in Montreal.
Points to be covered are:
- Items on the Meeting's agenda as per the Management Information
- Corporate Presentations
- MacoPharma presents update on launch of P-Capt(R) prion capture
- Protein Technologies business update
- Anemia drugs program update - PBI-1402 and analogues
- Corporate strategy to build shareholder value
Following these presentations shareholders and guests will have the opportunity of viewing displays on ProMetic's various products, as well as meeting members of management and scientists who will be gathered for the occasion.
For those who are unable to attend in person, the Company will offer a live audio webcast through ProMetic's website at http://www.prometic.com. A replay of the webcast will be available following the meeting on ProMetic's website.
About ProMetic Life Sciences Inc.
ProMetic Life Sciences Inc. ("ProMetic") (http://www.prometic.com) is a
biopharmaceutical company specialized in the research, development,
manufacture and marketing of a variety of commercial applications derived
from its proprietary Mimetic Ligand(TM) technology. This technology is used
in large-scale purification of biologics and the elimination of pathogens.
ProMetic is also active in therapeutic drug development with the mission to
bring to market effective, innovative, lower cost, less toxic products for
the treatment of hematology and cancer. Its drug discovery platform is
focused on re
|SOURCE PROMETIC LIFE SCIENCES INC.|
Copyright©2008 PR Newswire.
All rights reserved